Comment on

• Comparison of photoselective green light laser vaporisation versus traditional transurethral resection for benign prostate hyperplasia: an updated systematic review and meta-analysis of randomised controlled trials and prospective studies.

  Lai S, Peng P, Diao T, Hou H, Wang X, Zhang W, Liu M, Zhang Y, Seery S, Wang J. Lai S, et al. BMJ Open. 2019 Aug 21;9(8):e028855. doi: 10.1136/bmjopen-2018-028855. BMJ Open. 2019. PMID: 31439603 Free PMC article.
• Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analysis of a prospective, randomised, placebo-controlled study.

  Roehrborn CG, Rosen RC, Manyak MJ, Palacios-Moreno JM, Wilson TH, Lulic Z, Giuliano F. Roehrborn CG, et al. Int J Clin Pract. 2020 May;74(5):e13480. doi: 10.1111/ijcp.13480. Epub 2020 Feb 11. Int J Clin Pract. 2020. PMID: 31927774 Free PMC article. Clinical Trial.
• 3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction.

  Amparore D, Fiori C, Valerio M, Schulman C, Giannakis I, De Cillis S, Kadner G, Porpiglia F. Amparore D, et al. Prostate Cancer Prostatic Dis. 2021 Jun;24(2):349-357. doi: 10.1038/s41391-020-00281-5. Epub 2020 Oct 1. Prostate Cancer Prostatic Dis. 2021. PMID: 33005003